Net Cash Provided by (Used in) Financing Activities in USD of Accelerate Diagnostics, Inc from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Accelerate Diagnostics, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2011 to 2024.
  • Accelerate Diagnostics, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $11.4M.
  • Accelerate Diagnostics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $27.1M, a 200% increase from 2023.
  • Accelerate Diagnostics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $9.02M, a 71.5% decline from 2022.
  • Accelerate Diagnostics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $31.6M, a 26.8% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Accelerate Diagnostics, Inc Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11.4M +$11.5M 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024
Q1 2023 -$77K -$154K -200% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q1 2022 $77K -$11.8M -99.4% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q1 2021 $11.9M +$10.4M +730% 01 Jan 2021 31 Mar 2021 10-Q/A 03 Mar 2023
Q1 2020 $1.43M -$2.39M -62.6% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q1 2019 $3.82M -$98M -96.3% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q1 2018 $102M +$99.8M +4910% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q1 2017 $2.03M +$2.83M 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q1 2016 -$799K -$829K -2763% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017
Q1 2015 $30K -$694K -95.9% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q1 2014 $724K -$19.4M -96.4% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015
Q1 2013 $20.1M 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014
Q3 2012 $100K -$28.6K -22.2% 01 Aug 2012 31 Oct 2012 10-Q 14 Dec 2012
Q3 2011 $129K 01 Aug 2011 31 Oct 2011 10-Q 14 Dec 2012

Accelerate Diagnostics, Inc Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $27.1M +$18M +200% 01 Jan 2024 31 Dec 2024 10-K 21 Mar 2025
2023 $9.02M -$22.6M -71.5% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2025
2022 $31.6M -$11.6M -26.8% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024
2021 $43.2M +$31.6M +272% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2024
2020 $11.6M +$4.81M +70.5% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2023
2019 $6.82M -$119M -94.6% 01 Jan 2019 31 Dec 2019 10-K 14 Mar 2022
2018 $126M +$35.3M +39.1% 01 Jan 2018 31 Dec 2018 10-K 02 Mar 2021
2017 $90.4M +$88.7M +5032% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020
2016 $1.76M -$103M -98.3% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019
2015 $105M +$59.1M +129% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018
2014 $45.7M +$4.81M +11.8% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017
2013 $40.9M +$26.3M +181% 01 Jan 2013 31 Dec 2013 10-K 09 Mar 2016
2012 $14.5M +$14.4M +7383% 01 Aug 2011 31 Jul 2012 10-K 26 Feb 2015
2011 $194K 01 Aug 2010 31 Jul 2011 10-K 07 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.